Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Sulgi,Park

第一单位： Department of Molecular Medicine, University of Texas Health San Antonio, San Antonio, Texas.

作者： Sulgi,Park ^[1] ; Chung-Seog,Song ^[2] ; Chun-Lin,Lin ^[3] ; Shoulei,Jiang ^[1] ; Pawel A,Osmulski ^[3] ; Chiou-Miin,Wang ^[1] ; Brett T,Marck ^[1] ; Alvin M,Matsumoto ^[3] ; Colm,Morrissey ^[1] ; Maria E,Gaczynska ^[1] ; Yidong,Chen ^[4] ; Elahe A,Mostaghel ^[4] ; Bandana,Chatterjee ^[5]

作者单位： Department of Molecular Medicine, University of Texas Health San Antonio, San Antonio, Texas. ^[1] Department of Microbiology & Immunology, Pusan National University School of Medicine, South Korea. ^[2] South Texas Veterans Health Care System, San Antonio, Texas. ^[3] Geriatric Research, Education & Clinical Center, VA Puget Sound Health Care System, Seattle, WA. ^[4] Department of Urology, University of Washington, Seattle, WA. ^[5] Department of Epidemiology & Biostatistics, University of Texas Health San Antonio, San Antonio, Texas. ^[6] Greehy Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, Texas. ^[7] Fred Hutchinson Cancer Research Center, Seattle, WA. ^[8]

关键词 AKR1C3 aldo-keto reductase ERK1/2 survival signaling SULT2B1b sulfotransferase androgen receptor activity epithelial-to-mesenchymal transition prostate cancer